A PHASE 3, DOUBLE-BLIND, RANDOMIZED, TWO-PERIOD, MULTICENTER, PLACEBO CONTROLLED, EFFICACY AND SAFETY STUDY OF JNT-517 FOR THE TREATMENT OF PARTICIPANTS WITH PHENYLKETONURIA

Registry ID

JNT517-301 (359-201-00001)

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION INC

Start date

2026-03-16

Last update

2025-09-12

Conditions

• PHENYLKETONURIA

Related clinical trials

• A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SYNB1934 IN PATIENTS WITH PKU (SYNPHENY-3)

View on source registry